These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Psychiatric changes in patients treated with levodopa. I. The clinical experiment. Knopp W Neurology; 1970 Dec; 20(12):Suppl:23-30. PubMed ID: 4921585 [No Abstract] [Full Text] [Related]
4. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease. Muenter MD Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587 [No Abstract] [Full Text] [Related]
5. [Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations]. Barbieri NF; Megna GF; Micalizzi V; Pigneri MT; Puca FM Minerva Med; 1971 Oct; 62(82):4000-3. PubMed ID: 5125063 [No Abstract] [Full Text] [Related]
6. Letter: Long term mental changes in levodopa-treated patients. Botez MI; Barbeau A Lancet; 1973 Nov; 302(7836):1028-9. PubMed ID: 4127251 [No Abstract] [Full Text] [Related]
7. Psychiatric side effects of levodopa in man. Goodwin FK JAMA; 1971 Dec; 218(13):1915-20. PubMed ID: 5000569 [No Abstract] [Full Text] [Related]
8. Modification of Parkinsonism--chronic treatment with L-dopa. Cotzias GC; Papavasiliou PS; Gellene R N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641 [No Abstract] [Full Text] [Related]
9. [Effects of L-dopa on mental functions in parkinsonism]. Violon A; Peypers J; Rappel M Acta Psychiatr Belg; 1972 Mar; 72(2):168-84. PubMed ID: 5056014 [No Abstract] [Full Text] [Related]
10. Letter: Parkinsonism and dementia: effects of levodopa. Rajput AH; Rozdilsky B Lancet; 1975 May; 1(7915):1084. PubMed ID: 48746 [No Abstract] [Full Text] [Related]
11. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism]. Gerstenbrand F; Grünberger J; Schubert H Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895 [No Abstract] [Full Text] [Related]
12. Sexual behavior during L-dopa treatment for Parkinsonism. Bowers MB; Van Woert M; Davis L Am J Psychiatry; 1971 Jun; 127(12):1691-3. PubMed ID: 5565858 [No Abstract] [Full Text] [Related]
13. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis. Chase TN; Holden EM; Brody JA Arch Neurol; 1973 Nov; 29(5):328-33. PubMed ID: 4743883 [No Abstract] [Full Text] [Related]
14. Behavioral effects of l-dopa in man. Goodwin FK Semin Psychiatry; 1971 Nov; 3(4):477-92. PubMed ID: 5173049 [No Abstract] [Full Text] [Related]
15. Psychosis and other psychiatric manifestations of levodopa therapy. Celesia GG; Barr AN Arch Neurol; 1970 Sep; 23(3):193-200. PubMed ID: 5456717 [No Abstract] [Full Text] [Related]
16. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine. Holden EM; Brody JA; Chase TN Neurology; 1974 Mar; 24(3):263-5. PubMed ID: 4855953 [No Abstract] [Full Text] [Related]